Met Life Investment Management, LLC Corcept Therapeutics Inc Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
A detailed history of Met Life Investment Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 42,323 shares of CORT stock, worth $1.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,323Holding current value
$1.38 Million% of portfolio
0.01%Shares
35 transactions
Others Institutions Holding CORT
# of Institutions
314Shares Held
93.8MCall Options Held
2.02MPut Options Held
3.24M-
Black Rock Inc. New York, NY16.8MShares$547 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.57MShares$311 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY8.3MShares$270 Million9.24% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.12MShares$231 Million0.28% of portfolio
-
Parallel Advisors, LLC3.82MShares$124 Million2.62% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $3.48B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...